Details for 2011778283
Up to date per 03.04.2026
Actions
Details for 2011778283
Deleted
European Patent
13.03.2013 A
24.10.2018 B1
04.05.2010
US
331177 P
A61K 39/395 20060101AFI20150416BHEP
Owner
Five Prime Therapeutics, Inc.111 Oyster Point Boulevard94080 South San Francisco, CA US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
WONG, JustinFive Prime Therapeutics Inc. Two Corporate Drive South San Francisco, CA 94080US
VASQUEZ, MaximilianoFive Prime Therapeutics Inc. Two Corporate Drive South San Francisco, CA 94080US